U.S. License Holder:
Digestive Care Inc.
Date of License:
May-17-2012
Last Update:
Dec-15-2024
FDA-Approved Indications
PERTZYE (pancrelipase (amylase; lipase; protease)) is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.